Boston Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$381M Sell
1,558,577
-25,552
-2% -$5.95M 0.4% 86
2025
Q4
$328M Sell
1,584,129
-43,256
-3% -$8.55M 0.34% 96
2025
Q3
$302M Sell
1,627,385
-71,396
-4% -$12.2M 0.31% 111
2025
Q2
$260M Sell
1,698,781
-60,514
-3% -$9.3M 0.29% 122
2025
Q1
$292M Sell
1,759,295
-503,772
-22% -$78.8M 0.35% 95
2024
Q4
$327M Buy
2,263,067
+433,607
+24% +$67.2M 0.4% 84
2024
Q3
$296M Buy
1,829,460
+35,340
+2% +$5.63M 0.35% 101
2024
Q2
$262M Sell
1,794,120
-25,415
-1% -$3.78M 0.33% 114
2024
Q1
$288M Sell
1,819,535
-78,543
-4% -$12.5M 0.34% 108
2023
Q4
$298M Sell
1,898,078
-142,234
-7% -$21.8M 0.39% 92
2023
Q3
$318M Sell
2,040,312
-4,723,592
-70% -$779M 0.44% 81
2023
Q2
$1.12B Sell
6,763,904
-830,591
-11% -$134M 1.51% 2
2023
Q1
$1.18B Sell
7,594,495
-1,079,581
-12% -$174M 1.62% 4
2022
Q4
$1.53B Sell
8,674,076
-366,795
-4% -$63.3M 2.07% 1
2022
Q3
$1.48B Sell
9,040,871
-15,555
-0.2% -$2.63M 2.17% 1
2022
Q2
$1.61B Buy
9,056,426
+692,096
+8% +$123M 2.25% 1
2022
Q1
$1.48B Buy
8,364,330
+383,705
+5% +$65.3M 1.8% 2
2021
Q4
$1.37B Buy
7,980,625
+174,936
+2% +$28.6M 1.64% 2
2021
Q3
$1.26B Buy
7,805,689
+84,423
+1% +$14.4M 1.6% 3
2021
Q2
$1.27B Buy
7,721,266
+375,005
+5% +$62.1M 1.62% 1
2021
Q1
$1.21B Buy
7,346,261
+83,279
+1% +$13.5M 1.62% 2
2020
Q4
$1.14B Buy
7,262,982
+400,945
+6% +$59.2M 1.78% 1
2020
Q3
$1.02B Buy
6,862,037
+949,327
+16% +$140M 1.86% 2
2020
Q2
$832M Sell
5,912,710
-563,499
-9% -$82.1M 1.53% 3
2020
Q1
$849M Buy
6,476,209
+4,358,424
+206% +$618M 1.69% 4
2019
Q4
$309M Sell
2,117,785
-296,786
-12% -$40.3M 0.41% 73
2019
Q3
$312M Sell
2,414,571
-8,144,482
-77% -$1.07B 0.42% 75
2019
Q2
$1.47B Sell
10,559,053
-1,882,218
-15% -$261M 1.93% 2
2019
Q1
$1.74B Sell
12,441,271
-45,568
-0.4% -$6.1M 2.3% 2
2018
Q4
$1.61B Sell
12,486,839
-541,478
-4% -$75.5M 2.32% 2
2018
Q3
$1.8B Buy
13,028,317
+328,260
+3% +$43.6M 2.09% 2
2018
Q2
$1.54B Sell
12,700,057
-83,852
-0.7% -$10.5M 1.85% 4
2018
Q1
$1.64B Buy
12,783,909
+5,207,124
+69% +$704M 1.98% 4
2017
Q4
$1.06B Buy
7,576,785
+16,723
+0.2% +$2.33M 1.25% 10
2017
Q3
$983M Sell
7,560,062
-1,120,470
-13% -$149M 1.21% 13
2017
Q2
$1.15B Sell
8,680,532
-2,311,470
-21% -$295M 1.46% 6
2017
Q1
$1.37B Sell
10,992,002
-2,433,024
-18% -$291M 1.75% 3
2016
Q4
$1.55B Sell
13,425,026
-411,293
-3% -$47.5M 2.03% 3
2016
Q3
$1.63B Sell
13,836,319
-538,912
-4% -$65.4M 2.29% 1
2016
Q2
$1.74B Buy
14,375,231
+1,102,850
+8% +$125M 2.52% 1
2016
Q1
$1.44B Buy
13,272,381
+1,985,756
+18% +$206M 2.12% 3
2015
Q4
$1.16B Sell
11,286,625
-2,323,986
-17% -$234M 1.66% 7
2015
Q3
$1.27B Buy
13,610,611
+2,920,287
+27% +$282M 1.94% 4
2015
Q2
$1.04B Buy
10,690,324
+1,049,393
+11% +$105M 1.5% 7
2015
Q1
$970M Sell
9,640,931
-702,108
-7% -$71.4M 1.44% 8
2014
Q4
$1.08B Buy
10,343,039
+198,430
+2% +$20.9M 1.62% 7
2014
Q3
$1.08B Buy
10,144,609
+430,235
+4% +$44.6M 1.75% 7
2014
Q2
$1.02B Buy
9,714,374
+465,901
+5% +$47.1M 1.7% 8
2014
Q1
$908M Buy
9,248,473
+887,873
+11% +$82.3M 1.66% 7
2013
Q4
$766M Buy
8,360,600
+372,622
+5% +$34.3M 1.57% 7
2013
Q3
$692M Buy
7,987,978
+318,708
+4% +$28.6M 1.67% 8
2013
Q2
$658M Buy
+7,669,270
New +$651M 1.81% 8

Other funds holding JNJ

Boston Partners's JNJ Position: Q1 2026 in Review

Boston Partners reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $5.95M and leaving 1,558,577 shares worth $381M. The position accounts for 0.4% of the portfolio, ranked #86.

Boston Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.8B in Q3 2018. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Boston Partners held 1,558,577 shares of Johnson & Johnson worth $381M as of Q1 2026.
  • Boston Partners sold 25,552 Johnson & Johnson shares in Q1 2026, an estimated $5.95M.
  • Johnson & Johnson made up 0.4% of Boston Partners's portfolio in Q1 2026, its #86 holding.
  • Boston Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Boston Partners's Johnson & Johnson position peaked at $1.8B in Q3 2018.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.